Stereotaxis (STXS) Capital Expenditures (2010 - 2026)
Stereotaxis (STXS) reported Capital Expenditures of $79000.0 for Q1 2026, up 243.48% year-over-year from $23000.0 in Q1 2025, and up 12.86% quarter-over-quarter from $70000.0 in Q4 2025.
Stereotaxis (STXS) Capital Expenditures (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 14 years of Capital Expenditures data on file, last reported at $79000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $79000.0, up 243.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $149000.0 (up 325.71% YoY), and the FY2025 annual result was $93000.0, up 173.53% from the prior year.
- Capital Expenditures advanced to $79000.0 in Q1 2026 per STXS's latest filing, from $70000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.2 million in Q1 2022 and troughed at $2000.0 in Q4 2024.
- A 5-year average of $244000.0 and a median of $74500.0 in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures sank 98.92% in 2023, then surged 3400.0% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $369000.0 in 2022, then sank by 97.29% to $10000.0 in 2023, then slumped by 80.0% to $2000.0 in 2024, then surged by 3400.0% to $70000.0 in 2025, then grew by 12.86% to $79000.0 in 2026.
- Business Quant data shows STXS's Capital Expenditures at $79000.0 in Q1 2026, $70000.0 in Q4 2025, and $23000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 103.30 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 125.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 33.65 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 26.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 84.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 30.79 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 137.00 Mn |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn | 79,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,000.00 |
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 349,000.00 |
| Mar 31, 2023 | 349,000.00 |
| Dec 31, 2022 | 369,000.00 |
| Dec 31, 2022 | 369,000.00 |
| Sep 30, 2022 | 205,000.00 |
| Sep 30, 2022 | 205,000.00 |